Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...

Shares of MeiraGTx Holdings shares reached a 52-week high after the company said 11 children treated to date in a drug study gained visual acuity after treatment. The stock was recently up 9.1%, to $7 ...

MeiraGTx stock rose after publishing promising results from the first human trial using gene therapy to treat ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...

Holdings announced the publication of results from the first-in-human interventional study to treat children with ...

Orlando, FL - Micro Medical Devices (MMD), a longstanding innovator in the field of ophthalmic diagnostic technology, is set to showcase its latest advancements at Vision Expo East 2025 in Orlando, ...

Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...

A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...

Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding ...

MIAMI, Feb. 11, 2025 /PRNewswire/ -- Virtual Vision Health, a leader in Virtual Reality (VR) eye care technology, announced today the launch of Visual Acuity testing on the Virtual Eye VR platform.

Even when we think we are holding our gaze perfectly still, our eyes make tiny, involuntary movements. While these ...